124 related articles for article (PubMed ID: 19458621)
1. Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study.
Schoof N; von Bonin F; König IR; Mössner R; Krüger U; Reich K; Berking C; Volkenandt M; Ziegler A; Böckmann L; Kuschal C; Thoms KM; Kube D; Emmert S
Genes Immun; 2009 Sep; 10(6):586-90. PubMed ID: 19458621
[TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma.
Schoof N; Franklin J; Fürst R; Zander T; von Bonin F; Peyrade F; Trümper L; Diehl V; Engert A; Kube D; Re D
Oncologist; 2013; 18(1):80-9. PubMed ID: 23299779
[TBL] [Abstract][Full Text] [Related]
4. Involvement of interleukin-10 promoter polymorphisms in nonmelanoma skin cancers-a case study in non-Caucasian skin cancer patients.
Nagano T; Kunisada M; Yu X; Masaki T; Nishigori C
Photochem Photobiol; 2008; 84(1):63-6. PubMed ID: 18173702
[TBL] [Abstract][Full Text] [Related]
5. Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease.
Alonso R; Suarez A; Castro P; Lacave AJ; Gutierrez C
Melanoma Res; 2005 Feb; 15(1):53-60. PubMed ID: 15714121
[TBL] [Abstract][Full Text] [Related]
6. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study.
Blankenburg S; König IR; Moessner R; Laspe P; Thoms KM; Krueger U; Khan SG; Westphal G; Berking C; Volkenandt M; Reich K; Neumann C; Ziegler A; Kraemer KH; Emmert S
Carcinogenesis; 2005 Jun; 26(6):1085-90. PubMed ID: 15731165
[TBL] [Abstract][Full Text] [Related]
7. The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.
Vuoristo MS
Cancer Genet Cytogenet; 2007 Jul; 176(1):54-7. PubMed ID: 17574964
[TBL] [Abstract][Full Text] [Related]
8. IL-10 gene promoter and intron polymorphisms and changes in IL-10 secretion in women with idiopathic recurrent miscarriage.
Qaddourah RH; Magdoud K; Saldanha FL; Mahmood N; Mustafa FE; Mahjoub T; Almawi WY
Hum Reprod; 2014 May; 29(5):1025-34. PubMed ID: 24626804
[TBL] [Abstract][Full Text] [Related]
9. IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.
Zidi S; Gazouani E; Stayoussef M; Mezlini A; Ahmed SK; Yacoubi-Loueslati B; Almawi WY
Cytokine; 2015 Dec; 76(2):343-347. PubMed ID: 26076679
[TBL] [Abstract][Full Text] [Related]
10. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study.
Li C; Liu Z; Wang LE; Gershenwald JE; Lee JE; Prieto VG; Duvic M; Grimm EA; Wei Q
Int J Cancer; 2008 May; 122(9):2077-84. PubMed ID: 18183598
[TBL] [Abstract][Full Text] [Related]
11. IL-10 gene promoter polymorphisms and leprosy in a Colombian population sample.
Cardona-Castro N; Sánchez-Jiménez M; Rojas W; Bedoya-Berrío G
Biomedica; 2012; 32(1):71-6. PubMed ID: 23235789
[TBL] [Abstract][Full Text] [Related]
12. Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population.
Kong F; Liu J; Liu Y; Song B; Wang H; Liu W
J Exp Clin Cancer Res; 2010 Jun; 29(1):72. PubMed ID: 20553628
[TBL] [Abstract][Full Text] [Related]
13. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
[TBL] [Abstract][Full Text] [Related]
14. Association of extended interleukin-10 promoter haplotypes with disease susceptibility and manifestations in German patients with systemic lupus erythematosus.
Schotte H; Willeke P; Becker H; Poggemeyer J; Gaubitz M; Schmidt H; Schlüter B
Lupus; 2014 Apr; 23(4):378-85. PubMed ID: 24536045
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
[TBL] [Abstract][Full Text] [Related]
16. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
Howell WM; Turner SJ; Bateman AC; Theaker JM
Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma.
Oduor CI; Chelimo K; Ouma C; Mulama DH; Foley J; Vulule J; Bailey JA; Moormann AM
Am J Trop Med Hyg; 2014 Sep; 91(3):649-54. PubMed ID: 25071000
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
[TBL] [Abstract][Full Text] [Related]
19. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus.
Gibson AW; Edberg JC; Wu J; Westendorp RG; Huizinga TW; Kimberly RP
J Immunol; 2001 Mar; 166(6):3915-22. PubMed ID: 11238636
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
Wei YS; Kuang XH; Zhu YH; Liang WB; Yang ZH; Tai SH; Zhao Y; Zhang L
Tissue Antigens; 2007 Jul; 70(1):12-7. PubMed ID: 17559576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
